Paradigm Biopharmaceuticals Limited (PBIGF)
OTCMKTS · Delayed Price · Currency is USD
0.2300
0.00 (0.00%)
At close: Feb 10, 2026
PBIGF Market Cap
PBIGF has a market cap or net worth of $93.82 million as of February 12, 2026. Its market cap has decreased by -33.96% in one year.
Market Cap
93.82M
Enterprise Value
81.90M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.23
Market Cap Chart
Since August 19, 2015, PBIGF's market cap has increased from 23.75M to 93.82M, an increase of 295.00%. That is a compound annual growth rate of 13.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 93.82M | -3.46% |
| Dec 31, 2025 | 97.18M | 7.53% |
| Dec 31, 2024 | 90.37M | -11.25% |
| Dec 29, 2023 | 101.83M | -62.22% |
| Dec 30, 2022 | 269.52M | -14.36% |
| Dec 31, 2021 | 314.70M | -30.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 214.44M |
| HST Global | 139.70M |
| Vaxart | 137.92M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 72.43M |
| VitaSpring Biomedical | 51.78M |
| Vicapsys Life Sciences | 48.56M |
| Arch Biopartners | 43.92M |